A New Zealand bladder cancer detection firm is opening its U.S. office at the biotechnology incubator Hershey Center for Applied Research, in a move that will add 100 jobs over three years.
Pacific Edge Diagnostics will market its bladder cancer detection test, Cx Bladder, to urologists at the end of the year, according to a statement from the company. Its 11,348-square-foot offices will be located by the technology suites — a project funded by the economic development administration of the state’s commerce department to provide subsidized lab and office suites for technology companies that is set to open in August.
The five-year-old center has a strategic partnership with Penn State University and the Penn State Milton S. Hershey Medical Center.
HCAR currently has $2 million in capital available for companies looking to locate to its Knowledge Community incubator, according to a statement from the center.
Pacific Edge Diagnostics is the 12th company at the facility and the third from the Australia and New Zealand region.
Reserve your seat now for MedCity CONVERGE, to be held July 9-10 in Philadelphia. Discover strategies, solutions and startups in healthcare innovation. Be a part of this gathering where the entire healthcare ecosystem converges.
By Stephanie Baum
Stephanie Baum is the East Coast Innovation Reporter for MedCityNews.com. She enjoys covering healthcare startups across health IT, drug development and medical devices and innovations deployed to improve medical care. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's written for The Christian Science Monitor, Dow Jones & Co. and United Business Media.Visit website | More posts by Author
- Get Livefyre
- FAQ
